anti-viral drug

New Delhi: Leading pharmaceutical company Cipla has sought permission to launch Favipiravir, an anti-viral drug, in India to fight against COVID-19. Sources said the Council of Scientific and Industrial Research (CSIR) had developed an…

Another anti-viral drug for the treatment of COVID-19 has been launched, this time by pharma major Cipla. To be sold in the market under the brand name of Cipremi, this one is a generic version of antiviral drug Remdesivir to be used in…